Literature DB >> 2509465

Ganglioside-modulated protein phosphorylation in muscle. Activation of phosphorylase b kinase by gangliosides.

K F Chan1.   

Abstract

Gangliosides have profound effects on protein phosphorylation in skeletal muscle. Addition of GT1b to guinea pig muscle extract stimulated the phosphorylation of a 98-kDa protein 4-8-fold. In contrast, Ca2+ stimulated the phosphorylation of this protein and two other proteins with apparent Mr of 107,000 and 145,000, respectively. Addition of GT1b in the presence of Ca2+ further enhanced the phosphorylation of the 98-kDa protein but completely inhibited the phosphorylation of both the 107- and the 145-kDa proteins. The nature of the ganglioside-modulated 98-kDa protein has been characterized. Results on the pH activity profiles and the requirements of Ca2+ for phosphorylation suggest that this phosphoprotein may correspond to glycogen phosphorylase. Phosphorylation of purified rabbit muscle phosphorylase b by nonactivated phosphorylase kinase was stimulated by GT1b. This stimulation was in part due to an activation of the kinase activity. Autophosphorylation of highly purified phosphorylase kinase was increased 4-10-fold in the presence of GT1b. Polysialogangliosides were more potent than monosialogangliosides in stimulating the autocatalytic activity, whereas asialo-GM1, colominic acid, N-acetylneuraminic acid, and phosphatidylserine were ineffective. The effects of gangliosides were dose-dependent. At physiological pH, the concentrations of GT1b required for half-maximal stimulation of the autophosphorylation of phosphorylase kinase were 6.4 microM in the absence of Ca2+ and 1.3 microM when the divalent cation was present. These findings suggest that gangliosides may play a role as biomodulators in the regulation of glycogenolysis in muscle.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509465

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Cell regulation by sphingosine and more complex sphingolipids.

Authors:  A H Merrill
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

Review 2.  Ganglioside function in calcium homeostasis and signaling.

Authors:  Robert W Ledeen; Gusheng Wu
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 3.  Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.

Authors:  Marco Piccinini; Federica Scandroglio; Simona Prioni; Barbara Buccinnà; Nicoletta Loberto; Massimo Aureli; Vanna Chigorno; Elisa Lupino; Giovanni DeMarco; Annarosa Lomartire; Maria Teresa Rinaudo; Sandro Sonnino; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.590

4.  Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.

Authors:  J Müthing; M Cacić
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

5.  Expression of neutral glycosphingolipids and gangliosides in human skeletal and heart muscle determined by indirect immunofluorescence staining.

Authors:  M Cacić; J Müthing; I Kracun; U Neumann; S Weber-Schürholz
Journal:  Glycoconj J       Date:  1994-10       Impact factor: 2.916

6.  Glycolipids of a human glioma cell line bearing receptors for platelet-derived growth factor (PDGF).

Authors:  A J Yates; J D Agudelo; C C Sung
Journal:  Lipids       Date:  1992-04       Impact factor: 1.880

7.  Immunohistological analyses of neutral glycosphingolipids and gangliosides in normal mouse skeletal muscle and in mice with neuromuscular diseases.

Authors:  M Cacic; K Sostarić; S Weber-Schürholz; J Müthing
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

8.  Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages.

Authors:  P R Crocker; S Kelm; C Dubois; B Martin; A S McWilliam; D M Shotton; J C Paulson; S Gordon
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.